4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-24-015137
SR. VP & CPDO sold 38,597 shares at $33.64 ($1,298,384)
- SR. VP & CPDO acquired 42,945 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Crowley Elizabeth SR. VP & CPDO | 2024-05-30 | Option exercise | +34,445 | $2.78 | $95,757 | 39,171 | D |
| Crowley Elizabeth SR. VP & CPDO | 2024-05-30 | Option exercise | +8,500 | $9.02 | $76,640 | 47,671 | D |
| Crowley Elizabeth SR. VP & CPDO | 2024-05-30 | Sale | −38,597 | $33.64 | $1,298,384 | 9,074 | D |
| Derivatives | |||||||
| Crowley Elizabeth SR. VP & CPDO | 2024-05-30 | Option exercise · Incentive Stock Option (Right to Buy) | −34,445 | 0 | D | ||
| Crowley Elizabeth SR. VP & CPDO | 2024-05-30 | Option exercise · Incentive Stock Option (Right to Buy) | −8,500 | 7,500 | D | ||
| Open-market sales · 38,597 sh · avg $33.64 · $1,298,384 | |||||||
Loading xslF345X05/form4-06032024_080604.xml…